Document Detail


Gonadotropin-releasing hormone agonist trigger: the way to eliminate ovarian hyperstimulation syndrome--a 20-year experience.
MedLine Citation:
PMID:  21082509     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
Gonadotropin-releasing hormone agonist (GnRHa) trigger instead of human chorionic gonadotropin in the context of ovarian hyperstimulation syndrome (OHSS) prevention has been used for >20 years. In its first decade it did not gain popularity because it cannot work in GnRHa-based ovarian stimulation protocols. The introduction of GnRH antagonists has revolutionized our ability to eliminate OHSS completely because patients at high risk for OHSS can be triggered with GnRHa. This has been documented in randomized prospective studies, in which none of the patients randomized to the agonist trigger arm developed OHSS. In other words, GnRHa proved to be a potent tool that, truly remarkably, never fails. Although there is some debate concerning the clinical outcome of these cycles, data so far indicate that aggressive luteal support can ensure a good outcome. Moreover, the large number of frozen embryos in these cycles results in excellent per-oocyte retrieval pregnancy rates. In summary, GnRHa ovulatory trigger is the ultimate tool for complete OHSS prevention. GnRH antagonist-based ovarian stimulation protocols should be considered in OHSS high-risk patients so GnRHa trigger can be used if needed.
Authors:
Shahar Kol; Joseph Itskovitz-Eldor
Related Documents :
8458459 - The difference in miscarriage rates between menotropin-induced and natural cycle pregna...
3932569 - In vitro fertilization and embryo transfer: an individualized approach to ovulation ind...
6692959 - Polycystic ovarian syndrome treated by ovarian electrocautery through the laparoscope.
8290179 - The temporal relation between the urine lh surge and sonographic evidence of ovulation:...
16048799 - Antral follicle assessment after down-regulation may be a useful tool for predicting pr...
16715879 - The effect of gnrh or oestradiol injected at pro-oestrus on luteal function and follicu...
20121529 - Estimating the effect of gestational age on test performance of combined first-trimeste...
12871889 - Clinical outcomes following interval laparoscopic transabdominal cervico-isthmic cercla...
15090929 - Botulinum toxin in a case of hemimasticatory spasm with severe worsening during pregnancy.
Publication Detail:
Type:  Journal Article     Date:  2010-11-16
Journal Detail:
Title:  Seminars in reproductive medicine     Volume:  28     ISSN:  1526-4564     ISO Abbreviation:  Semin. Reprod. Med.     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-11-18     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100909394     Medline TA:  Semin Reprod Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  500-5     Citation Subset:  IM    
Copyright Information:
© Thieme Medical Publishers.
Affiliation:
Department of Obstetrics and Gynecology, Rambam Health Care Campus, Haifa, Israel.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Ovarian hyperstimulation syndrome prevention strategies: use of gonadotropin-releasing hormone antag...
Next Document:  Ovarian hyperstimulation syndrome prevention strategies: Luteal support strategies to optimize pregn...